BREZTRI: payments to doctors
Payments that named BREZTRI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $29.9M
- Providers
- 87,308
- Transactions
- 453,113
- Average per transaction
- $66
The per-transaction average — $66 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 87,308 providers the average total is $343, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $29,443,694 | 98.4% |
| Astrazeneca UK Limited | $481,514 | 1.6% |
| Astrazeneca AB | $4,028 | 0.0% |
| Acerta Pharma LLC | $2,996 | 0.0% |